Thoracic Radiotherapy Plus Durvalumab in Elderly and/or Frail NSCLC Stage III Patients Unfit for Chemotherapy
Clinical trial NCT04351256 · COMPLETED
Trial details
- NCT number
- NCT04351256
- Sponsor
- Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-20
- Primary completion
- 2026-01-21
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.